Parkinson's Disease

🧠 Standard of Care

Parkinson's disease (PD) treatment is highly individualized. Management typically involves a combination of prescription medications to manage motor symptoms and intensive lifestyle adjustments.

• Movement Disorder Specialists: Care should ideally be overseen by a neurologist specializing in movement disorders.
• Physical Exercise: Regular, intensive exercise (like Tai Chi, cycling, or boxing) is the only intervention strongly correlated with slowing physical decline.
• Medication Timing: PD medications are "time-critical." Skipping or delaying doses can lead to severe physical freezing ("off" periods).

💊 Prescribed Medications

Most medications work to replenish or mimic dopamine in the brain.

Carbidopa-Levodopa

The gold standard. Levodopa converts to dopamine in the brain. Carbidopa prevents the premature breakdown of Levodopa in the bloodstream, severely reducing nausea side effects.

Dopamine Agonists (Pramipexole, Ropinirole)

These drugs directly mimic the effects of dopamine and are often used as an alternative or alongside Levodopa to smooth out "off" periods.

MAO-B & COMT Inhibitors

These medications prevent the enzymatic breakdown of naturally occurring dopamine or administered Levodopa, prolonging symptom relief.

🌿 Over-The-Counter (OTC) Therapies

Many patients explore OTC supplements, but evidence is heavily lacking.

• Coenzyme Q10 (CoQ10) & Vitamin E: Frequently discussed for neuroprotection, but large-scale clinical trials have failed to prove efficacy.
• Mucuna Pruriens: A natural source of Levodopa. However, it is unregulated, making precise dosing impossible.

🔬 Clinical Trials

Clinical trials are constantly recruiting to find a cure and better management tools. Here are some currently recruiting trials derived directly from ClinicalTrials.gov:

• NCT06977204 (C. Mondino Foundation): The MOVE-ON study investigating the role of physical activity on neuroinflammation in Parkinson's Disease.
• NCT07226284 (University of Minnesota): A study evaluating the effects of Vagus Nerve Stimulation on intrinsic lower leg spinal motoneuron excitability and posture in Parkinson's Disease.
• NCT07322887 (GEN Ilaç ve Sağlık Ürünleri A.Ş.): The SHEPHERD Phase 2 study assessing the effects of SUL-238 on high energy phosphates using Magnetic Resonance Spectroscopy in patients with early, untreated Parkinson's Disease.

❓ Patient FAQ

Q: Can Parkinson's disease be cured?
A: Currently, there is no cure for Parkinson's disease, but medications, therapies, and lifestyle modifications can significantly relieve symptoms and maintain quality of life.

Q: Is Parkinson's hereditary?
A: Most cases of Parkinson's are not directly inherited. However, having a first-degree relative with the disease slightly increases the risk, and specific genetic mutations (like LRRK2) are linked to a small percentage of cases.

Q: Why does my medication wear off before the next dose?
A: As the disease progresses, the brain's ability to store dopamine decreases. This causes the "wearing-off" phenomenon. Neurologists may adjust dosing frequency or add adjunct medications to smooth out these fluctuations.

🗺️ Next Steps After Diagnosis

Being diagnosed with Parkinson's can be overwhelming. Here is a guided roadmap for your first 6 months:

1. Build Your Team: Don't rely solely on a general practitioner. Seek out a Movement Disorder Specialist (a neurologist with additional training in PD), a physical therapist, and a speech-language pathologist.
2. Start Moving Immediately: Do not wait for symptoms to worsen. Enroll in a PD-specific exercise program like Rock Steady Boxing or LSVT BIG. High-intensity exercise is neuroprotective.
3. Organize Your Meds: Precision is everything. Use pill organizers and phone alarms to ensure you take your Carbidopa-Levodopa at the exact same times every day. Avoid taking it with high-protein meals, which block absorption.
4. Explore Clinical Trials: Many promising therapies are only available through trials. Check our Clinical Trials Catalogue to see if you qualify for early-stage neuroprotective studies.